Skip to content

阿玛达收购公司二号

US · XRPN #3424 按市值排名
15.45 -0.62 -3.86%
实时 - 追踪5344个代码 - 心跳于136秒前 · 2026-10-16 20:02

估值 各估值倍数与自身5年区间的对比

市净率 3.49 高于历史水平 第99百分位
5年平均 1.51 · 在Shell Companies中排名第289/306
市盈率 252.63 高于历史水平 第99百分位
5年平均 -6.28 · 在Shell Companies中排名第88/96
市销率 --
5年平均 0.00

同业对比 Shell Companies

公司 市值 市盈率(TTM) 市净率 股息率
阿玛达收购公司二号 (XRPN) 841.73M -50.82 5.55 0.00%
Vylor Inc (VYLR) 48.16B 101.81 3.17 0.00%
DRUGS MADE IN AMERICA ACQ II CORP (DMII) 648.47M 34.86 1.31 0.00%
EQV VENTURES ACQUISITION CORP. II (EVAC) 602.60M 14.75 1.31 0.00%
Bain Capital GSS Investment (BCSS) 596.26M 0.00 1.30 0.00%
Churchill Capital Corp XI (CCXI) 593.76M 0.00 2.21 0.00%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★★★ 合理价值36.62 经济护城河Narrow 不确定性High

当前股价低于晨星合理价值估算137.1%。

合理价值

Armada Acquisition Corp II is assigned a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 32% discount to our quantitative fair value estimate of $36.62 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's liquidity bolsters our fair value estimate. Low liquidity may indicate efficient capital use and strong investment opportunities. Reflecting the firm's liquidity is its median trading volume over the past 60 days, which sits in the bottom 40% globally. Relatively low trading volume for these shares could lead to prices that don't accurately reflect the intrinsic value of shares. We believe this is a sign that shares could be cheap.

On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 18.2%, for example, ranks in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.

经济护城河

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 20:02:30 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

阿玛达收购公司二号 讨论区 0 条评论

发表评论